| COVID-19 |
1 |
1 |
| Acute Respiratory Distress Syndrome |
0 |
0.64 |
| Severe Acute Respiratory Syndrome |
0 |
0.47 |
| Central Nervous System |
0 |
0.99 |
| Child |
0 |
0.98 |
| New York |
0 |
0.38 |
| Cerebrospinal Fluid |
0 |
0.3 |
| Medical Life |
0 |
0.3 |
| Anxiety Disorder |
0 |
0.26 |
| Nutritional Support |
0 |
0.25 |
| Immunoglobulin G (IgG) |
0 |
0.21 |
| Anxiety |
0 |
0.19 |
| Clinician Health and Well-Being |
0 |
0.19 |
| Depression |
0 |
0.19 |
| Hospital |
0 |
0.19 |
| Insomnia |
0 |
0.19 |
| Residency |
0 |
0.19 |
| Sleep Disorders |
0 |
0.17 |
| Adolescent Medicine |
0 |
0.97 |
| Brain |
0 |
0.14 |
| Intravenous Immunoglobulin (IVIG) |
0 |
0.11 |
| Aggression |
0 |
0.09 |
| Biologic Therapy |
0 |
0.09 |
| Fellowship |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Immunoglobulin A (IgA) |
0 |
0.09 |
| Immunotherapy |
0 |
0.09 |
| White Blood Cell Count |
0 |
0.07 |
| Accomodation |
0 |
0.05 |
| Agitation |
0 |
0.05 |
| Anorexia Nervosa |
0 |
0.05 |
| Apraxia |
0 |
0.05 |
| Blood |
0 |
0.05 |
| C-Reactive Protein (CRP) |
0 |
0.05 |
| California |
0 |
0.05 |
| Delusions |
0 |
0.05 |
| Fever |
0 |
0.05 |
| Fluid, Electrolyte, and Nutrition Management of the Newborn |
0 |
0.05 |
| Intravenous |
0 |
0.05 |
| Memory |
0 |
0.05 |
| Mental Illness |
0 |
0.05 |
| Psychiatric History |
0 |
0.05 |
| Serology |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| Cerebrovascular Accident |
0 |
0.04 |
| Eating Disorders |
0 |
0.04 |
| Schizophrenia |
0 |
0.04 |